Grifols, S.A.

$11.12+5.20%(+$0.55)
TickerSpark Score
68/100
Solid
93
Valuation
75
Profitability
70
Growth
72
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GIFLF research report →

52-Week Range48% of range
Low $8.50
Current $11.12
High $14.00

Companywww.grifols.com

Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives.

CEO
Jose Ignacio Abia Buenache
IPO
2008
Employees
23,833
HQ
Barcelona, ES

Price Chart

+30.82% · this period
$14.00$11.25$8.50May 20Nov 18May 20

Valuation

Market Cap
$7.57B
P/E
15.68
P/S
0.88
P/B
1.19
EV/EBITDA
10.80
Div Yield
1.57%

Profitability

Gross Margin
37.68%
Op Margin
16.89%
Net Margin
5.58%
ROE
7.88%
ROIC
5.49%

Growth & Income

Revenue
$7.52B · 4.28%
Net Income
$401.74M · 156.02%
EPS
$0.59 · 168.18%
Op Income
$1.25B
FCF YoY
47.27%

Performance & Tape

52W High
$14.00
52W Low
$8.50
50D MA
$11.41
200D MA
$12.54
Beta
1.17
Avg Volume
1.20K

Get TickerSpark's AI analysis on GIFLF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our GIFLF Coverage

We haven't published any research on GIFLF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate GIFLF Report →

Similar Companies